跳至主要内容
临床试验/CTRI/2023/03/050796
CTRI/2023/03/050796已完成4 期

“Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types

Dabur India Limited1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2023年3月21日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
24
试验地点
1
主要终点
1.Number of subjects that showed

研究概览

简要总结

Irritants are substances that provoke immediate response in the skin perceived as a superficial skin reaction in terms of erythema, oedema and/or papules. The severity of irritation depends upon the nature, concentration, and duration of exposure. Irritation is manifested as inflammatory responses such as erythema (redness), oedema (swelling), and vesiculation and finally, to an intense supportive reaction without the involvement of the immune system. In this patch test the irritation potential of a substance is assessed by a single application of patch under complete occlusion for 24 hrs

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Voluntary men and women ratio of 1:1 between 18 and 65 years.
  • 2.Having healthy skin on test area as assessed by dermatological examination.
  • 3.For whom the investigator considers that the compliance will be correct.
  • 4.Subjects with normal, dry, oily and combination skin 5.Subjects cooperating informed of the need and duration of the examination and ready to comply with protocol procedures.

排除标准

  • 1.Pregnant/nursing mothers.
  • 2.Scars, excessive terminal hair, or tattoo on the studied area.
  • 3.Dermatological infection/pathology on level of studied area.
  • 4.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material) 5.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.

结局指标

主要结局

1.Number of subjects that showed

时间窗: Day 1, Day 2, Day 3, Day 8

Score of less than or equal to 2 on the Draize scale.

时间窗: Day 1, Day 2, Day 3, Day 8

2.No significant irritation.

时间窗: Day 1, Day 2, Day 3, Day 8

次要结局

  • NA(NA)

研究者

申办方类型
Other [consumer goods company]

研究点 (1)

Loading locations...

相似试验

Safety evaluation of test products on healthy skin... | 临床试验